Showing results (2171-2180 of 2,533) with videos related to

Sort By:
Pageof 254
Cell Death & Disease|September 24, 2021
Inhibition of Notch activity promotes pancreatic cytokeratin 5-positive cell differentiation to beta cells and improves glucose homeostasis following acute pancreatitisXiaoyi Zhang, Jing Tao, Jia Yu, et al.
Journal of Neuroinflammation|February 14, 2019
AMPK activation attenuates inflammatory pain through inhibiting NF-κB activation and IL-1β expressionHong-Chun Xiang, Li-Xue Lin, Xue-Fei Hu, et al.
Current Stem Cell Research & Therapy|October 28, 2025
Therapeutic Role of Bone Marrow Mesenchymal Stem Cells (BMSCs) in Nonalcoholic Steatohepatitis (NASH) CirrhosisHai-Tang Jiang, Hao-Ming Ye, Hua-Yang Yu, et al.
Parkinsonism & Related Disorders|February 12, 2013
Spectrum and characterization of movement disorders secondary to neurosyphilisMan-Li Tong, Li-Rong Lin, Hui-Lin Zhang, et al.
Diagnostic Microbiology and Infectious Disease|February 23, 2013
Laboratory findings in neurosyphilis patients with epileptic seizures alone as the initial presenting symptomMan-Li Tong, Li-Li Liu, Yan-Li Zeng, et al.
Kidney International|May 30, 2013
Host APOL1 genotype is independently associated with proteinuria in HIV infectionMichelle M Estrella, Christina M Wyatt, C Leigh Pearce, et al.
Theranostics|November 18, 2020
An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancerSilei Sui, Xin An, Caiming Xu, et al.
Journal for Immunotherapy of Cancer|May 26, 2022
Bufalin stimulates antitumor immune response by driving tumor-infiltrating macrophage toward M1 phenotype in hepatocellular carcinomaZhuo Yu, Yuyao Li, Yue Li, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|July 20, 2019
Ganji Formulation for Patients with Hepatocellular Carcinoma Who Have Undergone Surgery: A Multicenter, Randomized, Double-Blind, Controlled TrialJing-Hao Zhang, Chao Zheng, Xiao-Jun Zhu, et al.
International Journal of Cancer|August 6, 2023
Real-world treatment patterns and outcomes of pyrotinib-based therapy in patients with HER2-positive advanced breast cancer (PRETTY): A nationwide, prospective, observational studyYiqun Li, Zhongsheng Tong, Xinhong Wu, et al.
Pageof 254